Insmed Inc., a global biopharmaceutical company, has appointed Sara Bonstein as chief financial officer, responsible for leading the company’s global financial operations, including financial planning and analysis, investor relations, accounting, tax and treasury. She will also serve as a member of Insmed’s Executive Committee. “Sara is an exciting addition to our management team as we continue our efforts to bring ARIKAYCE® to patients around the world,” said Will Le...